CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 38 filers reported holding CHEMBIO DIAGNOSTICS INC in Q1 2022. The put-call ratio across all filers is 2.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $12,494 | -85.3% | 56,869 | -56.1% | 0.00% | – |
Q2 2022 | $85,000 | -40.1% | 129,397 | -25.3% | 0.00% | – |
Q1 2022 | $142,000 | -83.6% | 173,223 | -77.1% | 0.00% | – |
Q4 2021 | $864,000 | -45.3% | 757,750 | +20.0% | 0.00% | – |
Q3 2021 | $1,579,000 | +249.3% | 631,672 | +315.1% | 0.00% | – |
Q2 2021 | $452,000 | -45.3% | 152,177 | -35.5% | 0.00% | – |
Q1 2021 | $827,000 | -86.1% | 235,761 | -81.1% | 0.00% | – |
Q4 2020 | $5,930,000 | +230.5% | 1,248,652 | +238.2% | 0.00% | – |
Q3 2020 | $1,794,000 | +109.3% | 369,256 | +40.0% | 0.00% | – |
Q2 2020 | $857,000 | – | 263,764 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |